产后出血期间的急性产科凝血病由纤溶亢进和异常纤维蛋白原血症引起:一项观察性队列研究
从11279例产妇中招募518例(4.6%)产后出血≥1000 mL或胎盘早剥、羊水栓塞或隐匿性出血的妇女,发现临床显著止血障碍不常见,但12例(1.06/1000产妇)出现以大量纤溶、低纤维蛋白原和异常纤维蛋白原血症为特征的急性产科凝血病,与50%的胎儿或新生儿死亡相关。
要点
- 产后出血≥1000 mL时,Clauss纤维蛋白原≤2 g/L者占2.4%,胎盘早剥者中为6/27(22.2%)。
- 出血>3000 mL的妇女有稀释性凝血病证据,但止血障碍不常见。
- 12例(1.06/1000产妇)出现急性产科凝血病,与50%的胎儿或新生儿死亡相关。
核心结论
- 产后出血期间临床显著止血障碍不常见,但一个亚组妇女有以纤溶亢进、低纤维蛋白原和异常纤维蛋白原血症为特征的独特严重凝血病,与不良胎儿结局相关。
研究设计与样本
- 观察性队列研究,从11279例产妇中招募518例(4.6%)产后出血≥1000 mL或胎盘早剥、羊水栓塞或隐匿性出血的妇女,收集常规凝血和黏弹性检测结果,对出血>2000 mL或凝血病风险增加的妇女检测储存血浆样本。
主要发现
- 产后出血≥1000 mL时,Clauss纤维蛋白原≤2 g/L者占2.4%,胎盘早剥者中为6/27(22.2%)。
- 出血>3000 mL的妇女有稀释性凝血病证据,但止血障碍不常见。
- 12例妇女(1.06/1000产妇)出现急性产科凝血病,特征为大量纤溶(纤溶酶/抗纤溶酶>40000 ng/mL)、D-二聚体升高、低纤维蛋白原血症、异常纤维蛋白原血症、因子V和因子VIII降低及活化蛋白C升高。
- 急性产科凝血病与50%的胎儿或新生儿死亡相关,并增加母亲发病率。
关键数值与推荐
- 产后出血≥1000 mL时,Clauss纤维蛋白原≤2 g/L者占2.4%,胎盘早剥者中为6/27(22.2%)。
- 急性产科凝血病特征:纤溶酶/抗纤溶酶>40000 ng/mL。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postpartum hemorrhage (PPH) may be exacerbated by hemostatic impairment. Information about PPH-associated coagulopathy is limited, often resulting in treatment strategies based on data derived from trauma studies. OBJECTIVES: To investigate hemostatic changes associated with PPH. PATIENTS/METHODS: From a population of 11 279 maternities, 518 (4.6%) women were recruited with PPH ≥ 1000 mL or placental abruption, amniotic fluid embolism, or concealed bleeding. Routine coagulation and viscoelastometric results were collated. Stored plasma samples were used to investigate women with bleeds > 2000 mL or those at increased risk of coagulopathy defined as placenta abruption, amniotic fluid embolism, or need for blood components. Procoagulant factors were assayed and global hemostasis was assessed using thrombin generation. Fibrinolysis was investigated with D-dimer and plasmin/antiplasmin complexes. Dysfibrinogenemia was assessed using the Clauss/antigen ratio. RESULTS: At 1000 mL blood loss, Clauss fibrinogen was ≤2 g/L in 2.4% of women and 6/27 (22.2%) cases of abruption. Women with very large bleeds (>3000 mL) had evidence of a dilutional coagulopathy, although hemostatic impairment was uncommon. A subgroup of 12 women (1.06/1000 maternities) had a distinct coagulopathy characterized by massive fibrinolysis (plasmin/antiplasmin > 40 000 ng/mL), increased D-dimer, hypofibrinogenemia, dysfibrinogenemia, reduced factor V and factor VIII, and increased activated protein C, termed acute obstetric coagulopathy. It was associated with fetal or neonatal death in 50% of cases and increased maternal morbidity. CONCLUSIONS: Clinically significant hemostatic impairment is uncommon during PPH, but a subgroup of women have a distinct and severe coagulopathy characterized by hyperfibrinolysis, low fibrinogen, and dysfibrinogenemia associated with poor fetal outcomes.
引用
- de Lloyd L, Jenkins PV, Bell SF, et al. Acute obstetric coagulopathy during postpartum hemorrhage is caused by hyperfibrinolysis and dysfibrinogenemia: an observational cohort study. J Thromb Haemost. 2022. PMID: 36696216. doi:10.1016/j.jtha.2022.11.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。